Literature DB >> 28493599

Spinal Cord Stimulator Implant Infection Rates and Risk Factors: A Multicenter Retrospective Study.

Bryan C Hoelzer1, Mark A Bendel1, Timothy R Deer2, Jason S Eldrige1, David R Walega3, Zhen Wang1, Shrif Costandi4, Gerges Azer4, Wenchun Qu1, Steven M Falowski5, Stephanie A Neuman6, Susan M Moeschler1, Catherine Wassef5, Christopher Kim2, Tariq Niazi4, Taher Saifullah4, Brian Yee2, Chong Kim2, Christine L Oryhan7, Joshua M Rosenow3, Daniel T Warren7, Imanuel Lerman8, Ruben Mora8, Salim M Hayek9, Michael Hanes9, Thomas Simopoulos10, Sanjiv Sharma10, Chris Gilligan10, Warren Grace2, Timothy Ade9, Nagy A Mekhail4, John P Hunter2, Daniel Choi11, Deborah Y Choi11.   

Abstract

OBJECTIVES: Spinal cord stimulation is an evidence-based treatment for a number of chronic pain conditions. While this therapy offers improvement in pain and function it is not without potential complications. These complications include device failure, migration, loss of therapeutic paresthesia, and infection. This article looked to establish a modern infection rate for spinal cord stimulators, assess the impact of known risk factors for surgical site infections and to determine the impact of certain preventative measures on the rate of infection.
METHODS: After institutional review board approval, a multisite, retrospective review was conducted on 2737 unique implants or revisions of SCS systems. Patient demographics, risk factors including diabetes, tobacco use, obesity, revision surgery, trial length, implant location, implant type, surgeon background, prophylactic antibiotic use, utilization of a occlusive dressing, and post-operative antibiotic use were recorded and analyzed.
RESULTS: The overall infection rate was 2.45% (n = 67). Diabetes, tobacco use, and obesity did not independently increase the rate of infection. Revision surgeries had a trend toward higher infection rate; however, this did not meet statistical significance. There was no difference in the rate of infection between implants performed by physicians of different base specialties, cylinder leads vs. paddle leads, or between different prophylactic antibiotics. Implants performed at academic centers had a higher rate of infection when compared to implants performed in nonacademic settings. When patients received an occlusive dressing or post-operative antibiotics they had a lower rate of infection.
CONCLUSIONS: The infection rate (2.45%) reported in this study is lower than the previously reported rates (3-6%) and are on par with other surgical specialties. This study did not show an increased rate of infection for patients that used tobacco, had diabetes or were obese. It's possible that given the low overall infection rate a larger study is needed to establish the true impact of these factors on infection. In addition, this study did not address the impact of poorly controlled diabetes mellitus (elevated hemoglobin A1c) vs. well-controlled diabetes. It can be concluded from this study that utilizing an occlusive dressing over the incision in the post-operative period decreases the rate of infection and should become the standard of care. This study also demonstrated the positive impact of post-operative antibiotics in decreasing the rate of infection. Studies in other surgical specialties have not shown this impact which would suggest that further research is needed.
© 2017 International Neuromodulation Society.

Entities:  

Keywords:  Antibiotic; complications; infection; spinal cord stimulation

Mesh:

Substances:

Year:  2017        PMID: 28493599     DOI: 10.1111/ner.12609

Source DB:  PubMed          Journal:  Neuromodulation        ISSN: 1094-7159


  12 in total

Review 1.  Neuromodulation in the Treatment of Painful Diabetic Neuropathy: A Review of Evidence for Spinal Cord Stimulation.

Authors:  Natalie H Strand; Adam R Burkey
Journal:  J Diabetes Sci Technol       Date:  2021-11-29

2.  Intrathecal Drug Delivery Systems Survey: Trends in Utilization in Pain Practice.

Authors:  Alaa Abd-Sayed; Kenneth Fiala; Jacqueline Weisbein; Pooja Chopra; Christopher Lam; Hemant Kalia; Navdeep Jassal; Amitabh Gulati; Dawood Sayed; Timothy Deer
Journal:  J Pain Res       Date:  2022-05-03       Impact factor: 2.832

Review 3.  Spinal cord stimulation programming: a crash course.

Authors:  Breanna Sheldon; Michael D Staudt; Lucian Williams; Tessa A Harland; Julie G Pilitsis
Journal:  Neurosurg Rev       Date:  2020-04-15       Impact factor: 3.042

4.  Reoperation Rates of Percutaneous and Paddle Leads in Spinal Cord Stimulator Systems: A Single-Center Retrospective Analysis.

Authors:  Devin D Antonovich; Willy Gama; Alexandra Ritter; Bethany Jacobs Wolf; Ryan H Nobles; Meron A Selassie; M Gabriel Hillegass
Journal:  Pain Med       Date:  2021-02-04       Impact factor: 3.637

5.  Advances in Interventional Therapies for Painful Diabetic Neuropathy: A Systematic Review.

Authors:  Li Xu; Zhuo Sun; Elizabeth Casserly; Christian Nasr; Jianguo Cheng; Jijun Xu
Journal:  Anesth Analg       Date:  2022-01-20       Impact factor: 6.627

6.  Spinal Cord Stimulation Infection Rate and Risk Factors: Results From a United States Payer Database.

Authors:  Steven M Falowski; David A Provenzano; Ying Xia; Alissa H Doth
Journal:  Neuromodulation       Date:  2018-08-17

7.  Management of post-cervical laminectomy fusion pain syndrome with a successful trial of spinal cord stimulation.

Authors:  Layth Dahbour; Thelma B Wright; Laert Rusha; Pushpinder Uppal; Kanchana Gattu; Seung J Lee; Blake Watterworth; Lynn Stansbury
Journal:  Pain Rep       Date:  2021-12-21

8.  Outcomes Associated With Infection of Chronic Pain Spinal Implantable Electronic Devices: Insights From a Nationwide Inpatient Sample Study.

Authors:  Vasudha Goel; Varun Kumar; Shivani N Agrawal; Amol M Patwardhan; Mohab Ibrahim; Daniel C DeSimone; Eellan Sivanesan; Ratan K Banik; Hariharan Shankar
Journal:  Neuromodulation       Date:  2020-09-14

9.  Postoperative Infections Associated With Prolonged Spinal Cord Stimulation Trial Duration (PROMISE RCT).

Authors:  Richard North; Mehul J Desai; Johan Vangeneugden; Christian Raftopoulos; Tony Van Havenbergh; Marc Deruytter; Jean-Michel Remacle; Jane Shipley; Ye Tan; Mary Jo Johnson; Carine Van den Abeele; Philippe Rigoard
Journal:  Neuromodulation       Date:  2020-04-08

Review 10.  Spinal Cord Stimulation for Neuropathic Pain: Current Trends and Future Applications.

Authors:  Ivano Dones; Vincenzo Levi
Journal:  Brain Sci       Date:  2018-07-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.